3-Aminopyrazole structure
|
Common Name | 3-Aminopyrazole | ||
|---|---|---|---|---|
| CAS Number | 1820-80-0 | Molecular Weight | 83.092 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 334.5±15.0 °C at 760 mmHg | |
| Molecular Formula | C3H5N3 | Melting Point | 34-37 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 182.6±7.6 °C | |
| Symbol |
GHS05, GHS07 |
Signal Word | Danger | |
| Name | 3-Aminopyrazole |
|---|---|
| Synonym | More Synonyms |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 334.5±15.0 °C at 760 mmHg |
| Melting Point | 34-37 °C(lit.) |
| Molecular Formula | C3H5N3 |
| Molecular Weight | 83.092 |
| Flash Point | 182.6±7.6 °C |
| Exact Mass | 83.048347 |
| PSA | 54.70000 |
| LogP | -0.29 |
| Vapour Pressure | 0.0±0.7 mmHg at 25°C |
| Index of Refraction | 1.648 |
| InChIKey | JVVRJMXHNUAPHW-UHFFFAOYSA-N |
| SMILES | Nc1ccn[nH]1 |
| Storage condition | 2-8°C |
| Symbol |
GHS05, GHS07 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H302-H314 |
| Precautionary Statements | P280-P305 + P351 + P338-P310 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | C:Corrosive; Xi:Irritant |
| Risk Phrases | R22;R34;R36/37/38 |
| Safety Phrases | S26-S36/37/39-S45 |
| RIDADR | UN 3263 8/PG 2 |
| WGK Germany | 3 |
| Hazard Class | 8.0 |
| HS Code | 2933199090 |
|
~99%
3-Aminopyrazole CAS#:1820-80-0 |
| Literature: Quinn, John F.; Bryant, Cole E.; Golden, Kathryn C.; Gregg, Brian T. Tetrahedron Letters, 2010 , vol. 51, # 5 p. 786 - 789 |
|
~60%
3-Aminopyrazole CAS#:1820-80-0 |
| Literature: Ege, Guenter; Franz, Hermann Journal of Heterocyclic Chemistry, 1982 , vol. 19, p. 1267 - 1273 |
|
~%
3-Aminopyrazole CAS#:1820-80-0 |
| Literature: Helvetica Chimica Acta, , vol. 39, p. 986,988 |
| Precursor 3 | |
|---|---|
| DownStream 10 | |
| HS Code | 2933199090 |
|---|---|
| Summary | 2933199090. other compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Trypanotoxic activity of thiosemicarbazone iron chelators.
Exp. Parasitol. 150 , 7-12, (2015) Only a few drugs are available for treating sleeping sickness and nagana disease; parasitic infections caused by protozoans of the genus Trypanosoma in sub-Saharan Africa. There is an urgent need for ... |
|
|
Vacuolar-ATPase Inhibition Blocks Iron Metabolism to Mediate Therapeutic Effects in Breast Cancer.
Cancer Res. 75 , 2863-74, (2015) Generalized strategies to improve breast cancer treatment remain of interest to develop. In this study, we offer preclinical evidence of an important metabolic mechanism underlying the antitumor activ... |
|
|
Analysis of gait in rats with olivocerebellar lesions and ability of the nicotinic acetylcholine receptor agonist varenicline to attenuate impairments.
Behav. Brain Res. 291 , 342-50, (2015) Studies have demonstrated that administration of the neuronal nicotinic receptor agonist varenicline to rats with olivocerebellar lesions attenuates balance deficits on a rotorod and balance beam, but... |
| 3-Pyrazolamine |
| 5-Pyrazolamine |
| 1H-pyrazol-3-ylamine |
| EINECS 217-338-1 |
| 5-AMINOPYRAZOLE |
| 3-amino-pyrazole |
| 3-AMINOPYROZOLE |
| 1H-Pyrazol-5-amine |
| 3-Amino-pyrazol |
| 3-Aminopyarazole |
| 1H-pyrazol-3-amine |
| MFCD00005236 |
| 3-AP |